# Bain Capital Specialty Finance, Inc.: financial statements, quarterly

BCSF · NYSE · CIK 1655050 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bcsf.md) · [Financials](/companies/bcsf/financials.md) · [Filings](/companies/bcsf/filings.md) · [Insiders](/companies/bcsf/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bcsf/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [20.8](/filings/0000950170-24-121464.md) | [19.2 d](/filings/0001193125-26-077703.md) | [18.1](/filings/0000950170-25-063596.md) | [17.6](/filings/0000950170-25-103202.md) | [18.1](/filings/0001193125-25-274163.md) | [20.9 d](/filings/0001193125-26-077703.md) | [18.9](/filings/0001193125-26-217068.md) | [21.8](/filings/0001193125-26-342491.md) | [20.3](/filings/0001193125-25-274163.md) | [19.6 d](/filings/0001193125-26-077703.md) | [20.3](/filings/0001193125-26-217068.md) | [20.7](/filings/0001193125-26-342491.md) |
| Income tax | $m | [0.0 d](/filings/0000950170-23-059452.md) | [0.0 d](/filings/0000950170-24-021337.md) | [0.0](/filings/0000950170-24-053555.md) | [0.0 d](/filings/0000950170-24-091840.md) | [0.0 d](/filings/0000950170-24-121464.md) | [0.0 d](/filings/0000950170-25-029152.md) | [0.0](/filings/0000950170-25-063596.md) | [0.0 d](/filings/0000950170-25-103202.md) | [0.0 d](/filings/0001193125-25-274163.md) | not reported | not reported | not reported |
| Net income | $m | [33.9](/filings/0001193125-26-077703.md) | [31.1](/filings/0001193125-26-077703.md) | [35.1](/filings/0001193125-26-077703.md) | [29.1](/filings/0001193125-26-077703.md) | [33.1](/filings/0001193125-26-077703.md) | [22.1](/filings/0001193125-26-077703.md) | [28.5](/filings/0001193125-26-217068.md) | [23.7](/filings/0001193125-26-342491.md) | [18.7](/filings/0001193125-26-077703.md) | [27.8](/filings/0001193125-26-077703.md) | [3.4](/filings/0001193125-26-217068.md) | [14.1](/filings/0001193125-26-342491.md) |
| Diluted EPS | $ per share | [0.52](/filings/0001193125-26-077703.md) | [0.48](/filings/0001193125-26-077703.md) | [0.55](/filings/0001193125-26-077703.md) | [0.45](/filings/0001193125-26-077703.md) | [0.51](/filings/0001193125-26-077703.md) | [0.34](/filings/0001193125-26-077703.md) | [0.44](/filings/0001193125-26-217068.md) | [0.37](/filings/0001193125-26-342491.md) | [0.29](/filings/0001193125-26-077703.md) | [0.43](/filings/0001193125-26-077703.md) | [0.05](/filings/0001193125-26-217068.md) | [0.22](/filings/0001193125-26-342491.md) |
| Basic EPS | $ per share | [0.52](/filings/0001193125-26-077703.md) | [0.48](/filings/0001193125-26-077703.md) | [0.55](/filings/0001193125-26-077703.md) | [0.45](/filings/0001193125-26-077703.md) | [0.51](/filings/0001193125-26-077703.md) | [0.34](/filings/0001193125-26-077703.md) | [0.44](/filings/0001193125-26-217068.md) | [0.37](/filings/0001193125-26-342491.md) | [0.29](/filings/0001193125-26-077703.md) | [0.43](/filings/0001193125-26-077703.md) | [0.05](/filings/0001193125-26-217068.md) | [0.22](/filings/0001193125-26-342491.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [65.2](/filings/0000950170-23-059452.md) | [43.0](/filings/0000950170-25-029152.md) | [46.7](/filings/0000950170-24-053555.md) | [18.4](/filings/0000950170-24-091840.md) | [25.3](/filings/0000950170-24-121464.md) | [51.6](/filings/0001193125-26-077703.md) | [10.2](/filings/0000950170-25-063596.md) | [27.8](/filings/0000950170-25-103202.md) | [40.9](/filings/0001193125-25-274163.md) | [23.1](/filings/0001193125-26-342491.md) | [13.0](/filings/0001193125-26-217068.md) | [97.2](/filings/0001193125-26-342491.md) |
| Total assets | $m | [2,566](/filings/0000950170-23-059452.md) | [2,472](/filings/0000950170-25-029152.md) | [2,580](/filings/0000950170-24-053555.md) | [2,415](/filings/0000950170-24-091840.md) | [2,544](/filings/0000950170-24-121464.md) | [2,632](/filings/0001193125-26-077703.md) | [2,642](/filings/0000950170-25-063596.md) | [2,774](/filings/0000950170-25-103202.md) | [2,716](/filings/0001193125-25-274163.md) | [2,663](/filings/0001193125-26-342491.md) | [2,602](/filings/0001193125-26-217068.md) | [2,620](/filings/0001193125-26-342491.md) |
| Total liabilities | $m | [1,434](/filings/0000950170-23-059452.md) | [1,336](/filings/0000950170-25-029152.md) | [1,438](/filings/0000950170-24-053555.md) | [1,272](/filings/0000950170-24-091840.md) | [1,397](/filings/0000950170-24-121464.md) | [1,492](/filings/0001193125-26-077703.md) | [1,498](/filings/0000950170-25-063596.md) | [1,635](/filings/0000950170-25-103202.md) | [1,587](/filings/0001193125-25-274163.md) | [1,545](/filings/0001193125-26-342491.md) | [1,508](/filings/0001193125-26-217068.md) | [1,540](/filings/0001193125-26-342491.md) |
| Long-term debt | $m | [1,370](/filings/0000950170-23-059452.md) | [1,256](/filings/0000950170-25-029152.md) | [1,358](/filings/0000950170-24-053555.md) | [1,174](/filings/0000950170-24-091840.md) | [1,301](/filings/0000950170-24-121464.md) | [1,390](/filings/0001193125-26-077703.md) | [1,451](/filings/0000950170-25-063596.md) | [1,563](/filings/0000950170-25-103202.md) | [1,496](/filings/0001193125-25-274163.md) | [1,471](/filings/0001193125-26-342491.md) | [1,455](/filings/0001193125-26-217068.md) | [1,501](/filings/0001193125-26-342491.md) |
| Shareholders' equity | $m | [1,133](/filings/0000950170-23-059452.md) | [1,136](/filings/0000950170-25-029152.md) | [1,143](/filings/0000950170-24-053555.md) | [1,143](/filings/0000950170-24-091840.md) | [1,147](/filings/0000950170-24-121464.md) | [1,140](/filings/0001193125-26-077703.md) | [1,145](/filings/0000950170-25-063596.md) | [1,139](/filings/0001193125-26-342491.md) | [1,129](/filings/0001193125-25-274163.md) | [1,117](/filings/0001193125-26-342491.md) | [1,094](/filings/0001193125-26-217068.md) | [1,080](/filings/0001193125-26-342491.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [122 d](/filings/0000950170-24-121464.md) | [149 d](/filings/0001193125-26-077703.md) | [(63.7)](/filings/0000950170-25-063596.md) | [192 d](/filings/0000950170-25-103202.md) | [(136) d](/filings/0001193125-25-274163.md) | [(20.0) d](/filings/0001193125-26-077703.md) | [(7.3)](/filings/0001193125-26-217068.md) | [0.6 d](/filings/0001193125-26-342491.md) | [9.0 d](/filings/0001193125-25-274163.md) | [27.2 d](/filings/0001193125-26-077703.md) | [26.6](/filings/0001193125-26-217068.md) | [70.8 d](/filings/0001193125-26-342491.md) |
| Dividends paid | $m | [24.5 d](/filings/0000950170-24-121464.md) | [27.1 d](/filings/0001193125-26-077703.md) | [27.1](/filings/0000950170-25-063596.md) | [29.1 d](/filings/0000950170-25-103202.md) | [29.1 d](/filings/0001193125-25-274163.md) | [29.1 d](/filings/0001193125-26-077703.md) | [58.2](/filings/0001193125-26-217068.md) | [29.2 d](/filings/0001193125-26-342491.md) | [29.2 d](/filings/0001193125-25-274163.md) | [29.2 d](/filings/0001193125-26-077703.md) | [37.0](/filings/0001193125-26-217068.md) | [27.2 d](/filings/0001193125-26-342491.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | period not labelled (2021-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [64.6](/filings/0001558370-22-017168.md) | [64.6](/filings/0000950170-24-053555.md) | [64.6](/filings/0000950170-24-091840.md) | [64.6](/filings/0000950170-24-121464.md) | [64.6](/filings/0000950170-25-063596.md) | [64.6](/filings/0000950170-25-103202.md) | [64.6](/filings/0001193125-25-274163.md) | [64.7](/filings/0001193125-26-217068.md) | [64.9](/filings/0001193125-26-342491.md) | [64.9](/filings/0001193125-25-274163.md) | [64.9](/filings/0001193125-26-217068.md) | [64.9](/filings/0001193125-26-342491.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 64,868,507 at 2026-08-10, from the cover of the [10-Q filed 2026-08-10](/filings/0001193125-26-342491.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.